Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474483 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19
A Phase 2 study, sponsored by State University of New York at Buffalo.
- Terminated
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT04474483 is a Phase 2 study that was terminated before completion, run by State University of New York at Buffalo. The registered enrollment target is 8 participants.
The verdict
NCT04474483, a Phase 2 study, was terminated before completion, sponsored by State University of New York at Buffalo.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study is a pilot randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of melatonin in adult outpatients suspected to be afflicted with COVID-19.
Interventions
- DRUG Melatonin
- OTHER Placebo (Methylcellulose) capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-11-06 |
| Est. Completion | 2022-07-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04474483
The ClinicalTrials.gov registry entry for NCT04474483 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Melatonin is the first listed.
NCT04474483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04474483 about?
NCT04474483 is a clinical study titled "Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19". This study is a pilot randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of melatonin in adult outpatients suspected to be afflicted with COVID-19.
What is the current status of trial NCT04474483?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2020-11-06. Estimated completion is 2022-07-22.
What interventions are being tested in trial NCT04474483?
The interventions under investigation include: Melatonin (DRUG), Placebo (Methylcellulose) capsule (OTHER).
Who is sponsoring clinical trial NCT04474483?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.